We then tested the effect of the pharmacological inhibition of MSI2 using Ro 08-2750 (Ro), a small molecule that inhibits MSI RNA-binding activity and has anti-proliferative activity in myeloid leukemia cells and chronic lymphocytic leukemia19,26. The gene discussed is MSI2; the disease is myeloid leukemia.